These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 2412681
1. Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer. Pizzocaro G, Pasi M, Salvioni R, Zanoni F, Milani A, Piva L. Cancer; 1985 Nov 15; 56(10):2399-403. PubMed ID: 2412681 [Abstract] [Full Text] [Related]
5. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis. Logothetis CJ, Samuels ML, Selig D, Swanson D, Johnson DE, von Eschenbach AC. J Clin Oncol; 1985 Mar 15; 3(3):326-35. PubMed ID: 2579213 [Abstract] [Full Text] [Related]
6. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution. Germá JR, Sagarra AF, Izquierdo MA, Seguí MA. Cancer; 1993 Feb 01; 71(3):796-803. PubMed ID: 7679314 [Abstract] [Full Text] [Related]
7. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. Wozniak AJ, Samson MK, Shah NT, Crawford ED, Ford CD, Altman SJ, Stephens RL, Natale RB, Bouroncle BA, Blumenstein BA. J Clin Oncol; 1991 Jan 01; 9(1):70-6. PubMed ID: 1702148 [Abstract] [Full Text] [Related]
8. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C. J Clin Oncol; 1991 Sep 01; 9(9):1549-55. PubMed ID: 1651992 [Abstract] [Full Text] [Related]
9. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE. J Urol; 2008 Jan 01; 179(1):163-6. PubMed ID: 18001800 [Abstract] [Full Text] [Related]
11. Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. Bosl GJ, Yagoda A, Golbey RB, Whitmore W, Herr H, Sogani P, Morse M, Vogelzang N, MacDonald G. Am J Med; 1985 Mar 01; 78(3):423-8. PubMed ID: 2983547 [Abstract] [Full Text] [Related]
15. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors]. Mori Y, Shima H, Ihara H, Yabumoto H, Iwasaki A, Yoshioka M, Ikoma F. Hinyokika Kiyo; 1992 Oct 01; 38(10):1139-42. PubMed ID: 1282774 [Abstract] [Full Text] [Related]
16. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin. Brada M, Horwich A, Peckham MJ. Cancer Treat Rep; 1987 Jun 01; 71(6):655-6. PubMed ID: 2438041 [Abstract] [Full Text] [Related]
17. Cisplatin combination chemotherapy in advanced seminoma. Pizzocaro G, Salvioni R, Piva L, Zanoni F, Milani A, Faustini M. Cancer; 1986 Oct 15; 58(8):1625-9. PubMed ID: 2428460 [Abstract] [Full Text] [Related]
18. Chemotherapy of refractory germ cell cancer with Etoposide. Lederman GS, Garnick MB, Canellos GP, Richie JP. J Clin Oncol; 1983 Nov 15; 1(11):706-9. PubMed ID: 6321675 [Abstract] [Full Text] [Related]
19. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Peckham MJ, Barrett A, Liew KH, Horwich A, Robinson B, Dobbs HJ, McElwain TJ, Hendry WF. Br J Cancer; 1983 May 15; 47(5):613-9. PubMed ID: 6189504 [Abstract] [Full Text] [Related]
20. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH. Ann Intern Med; 1988 Oct 01; 109(7):540-6. PubMed ID: 2844110 [Abstract] [Full Text] [Related] Page: [Next] [New Search]